Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bristol-Myers Squibb Company (BMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 88,866,144
  • Shares Outstanding, K 1,647,500
  • Annual Sales, $ 19,427 M
  • Annual Income, $ 4,457 M
  • 36-Month Beta 1.09
  • Price/Sales 4.54
  • Price/Cash Flow 17.44
  • Price/Book 5.47

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.51 +3.29%
on 04/06/17
56.55 -4.08%
on 03/29/17
-1.65 (-2.95%)
since 03/24/17
3-Month
47.12 +15.11%
on 01/27/17
58.54 -7.35%
on 03/10/17
+7.42 (+15.85%)
since 01/26/17
52-Week
46.01 +17.89%
on 01/26/17
77.12 -29.67%
on 07/15/16
-16.62 (-23.45%)
since 04/26/16

Most Recent Stories

More News
Pharma Stocks Q1 Earnings Roster for Apr 27: CELG, ABBV, BMY

Celgene, AbbVie and Bristol-Myers Squibb are expected to report earnings on Apr 27.

CELG : 126.05 (+0.42%)
JNJ : 124.03 (+0.49%)
ABBV : 65.44 (+0.52%)
BMY : 54.46 (+0.96%)
BIIB : 284.32 (-0.90%)
Exelixis (EXEL) Q1 Earnings: Will the Stock Disappoint?

Exelixis, Inc. (EXEL) is scheduled to report first-quarter 2017 results on May 1, after the market close.

PTI : 5.91 (-0.84%)
EXEL : 21.91 (-0.77%)
GILD : 67.68 (+0.83%)
BMY : 54.46 (+0.96%)
Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store?

Bristol-Myers Squibb Company (BMY) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.

MRK : 62.68 (+0.61%)
GILD : 67.68 (+0.83%)
ICPT : 114.93 (+0.14%)
BMY : 54.46 (+0.96%)
Look for Shares of Bristol-Myers Squibb to Potentially Pullback after Yesterday's 1.01% Rise

Bristol-Myers Squibb (NYSE:BMY) traded in a range yesterday that spanned from a low of $53.65 to a high of $54.32. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high...

BMY : 54.46 (+0.96%)
Watch for Shares of Bristol-Myers Squibb (BMY) to Approach Resistance at $54.01

Shares of Bristol-Myers Squibb (NYSE:BMY) have bullishly opened above the pivot of $53.45 today and have reached the first resistance level of $53.74. Analysts will be watching for a cross of the next...

BMY : 54.46 (+0.96%)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 139.56 (+0.69%)
JNJ : 124.03 (+0.49%)
MRK : 62.68 (+0.61%)
IYH : 157.97 (+0.62%)
FHLC : 36.20 (+0.58%)
ABBV : 65.44 (+0.52%)
AMG : 166.40 (+0.17%)
GILD : 67.68 (+0.83%)
SPY : 238.71 (+0.07%)
AMGN : 165.12 (+0.26%)
PFE : 33.95 (+0.56%)
BMY : 54.46 (+0.96%)
3 Key Factors to Look Out for in Biogen's Q1 Results

With Biogen (BIIB) set to report Q1 results tomorrow, here is a look at 3 key factors investors will be focused on apart from earnings and revenue.

MRK : 62.68 (+0.61%)
LLY : 81.16 (-0.05%)
BMY : 54.46 (+0.96%)
BIIB : 284.32 (-0.90%)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 139.56 (+0.69%)
JNJ : 124.03 (+0.49%)
MRK : 62.68 (+0.61%)
IYH : 157.97 (+0.62%)
FHLC : 36.20 (+0.58%)
ABBV : 65.44 (+0.52%)
AMG : 166.40 (+0.17%)
GILD : 67.68 (+0.83%)
SPY : 238.71 (+0.07%)
AMGN : 165.12 (+0.26%)
PFE : 33.95 (+0.56%)
BMY : 54.46 (+0.96%)
Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL

Key highlights from the pharma sector include J&J's (JNJ) first quarter results and a CRL for Lilly's RA drug.

JNJ : 124.03 (+0.49%)
LLY : 81.16 (-0.05%)
AGN : 240.18 (+0.82%)
NVS : 76.05 (-0.25%)
RHHBY : 32.1600 (-0.76%)
SNY : 46.33 (-0.15%)
BMY : 54.46 (+0.96%)
Is J&J's Pharma Sales Slowdown a Warning for Other Players?

Johnson & Johnson (JNJ) reported mixed first-quarter 2017 earnings results on Tuesday.

JNJ : 124.03 (+0.49%)
MRK : 62.68 (+0.61%)
AMGN : 165.12 (+0.26%)
PFE : 33.95 (+0.56%)
SNY : 46.33 (-0.15%)
BMY : 54.46 (+0.96%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Steady.

See More

Business Summary

Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain;...

See More

Support & Resistance

2nd Resistance Point 54.64
1st Resistance Point 54.29
Last Price 54.46
1st Support Level 53.62
2nd Support Level 53.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.